Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00391820 | Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial) | PHASE2 | COMPLETED | 360 | — | — | Oct 1, 2006 | May 1, 2007 | Jul 8, 2025 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| TD-5108 | DRUG | - |
Inclusion Criteria: * Meet ROME III Criteria Exclusion Criteria: * Constipation caused by:colonic etiology, pelvic floor dysfunction, metabolic disturbances, neurologic disturbances,concomitant medications affecting bowel function * Chronic treatment with anticholinergics, narcotic analgesics * I...